The Proteomics of Colorectal Cancer: Identification of a Protein Signature Associated with Prognosis

被引:74
作者
O'Dwyer, Donna [1 ]
Ralton, Lynda D. [1 ]
O'Shea, Aisling [1 ]
Murray, Graeme I. [1 ]
机构
[1] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland
基金
英国生物技术与生命科学研究理事会;
关键词
POOR-PROGNOSIS; EXPRESSION; MARKERS; BIOMARKERS; THERAPY; HSP60; CYTOCHROME-P450; PREDICTION; ANNEXINS; GROWTH;
D O I
10.1371/journal.pone.0027718
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Colorectal cancer is one of the commonest types of cancer and there is requirement for the identification of prognostic biomarkers. In this study protein expression profiles have been established for colorectal cancer and normal colonic mucosa by proteomics using a combination of two dimensional gel electrophoresis with fresh frozen sections of paired Dukes B colorectal cancer and normal colorectal mucosa (n = 28), gel image analysis and high performance liquid chromatography-tandem mass spectrometry. Hierarchical cluster analysis and principal components analysis showed that the protein expression profiles of colorectal cancer and normal colonic mucosa clustered into distinct patterns of protein expression. Forty-five proteins were identified as showing at least 1.5 times increased expression in colorectal cancer and the identity of these proteins was confirmed by liquid chromatography-tandem mass spectrometry. Fifteen proteins that showed increased expression were validated by immunohistochemistry using a well characterised colorectal cancer tissue microarray containing 515 primary colorectal cancer, 224 lymph node metastasis and 50 normal colonic mucosal samples. The proteins that showed the greatest degree of overexpression in primary colorectal cancer compared with normal colonic mucosa were heat shock protein 60 (p < 0.001), S100A9 (p < 0.001) and translationally controlled tumour protein (p, 0.001). Analysis of proteins individually identified 14-3-3 beta as a prognostic biomarker (chi(2) = 6.218, p = 0.013, HR = 0.639, 95% CL 0.448-0.913). Hierarchical cluster analysis identified distinct phenotypes associated with survival and a two-protein signature consisting of 14-3-3b and aldehyde dehydrogenase 1 was identified as showing prognostic significance (chi(2) = 7.306, p = 0.007, HR = 0.504, 95% CL 0.303-0.838) and that remained independently prognostic (p = 0.01, HR = 0.416, 95% CL 0.208-0.829) in a multivariate model.
引用
收藏
页数:15
相关论文
共 51 条
[1]   The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase -: art. no. 139 [J].
Cappello, F ;
David, S ;
Rappa, F ;
Bucchieri, F ;
Marasà, L ;
Bartolotta, TE ;
Farina, F ;
Zummo, G .
BMC CANCER, 2005, 5 (1)
[2]  
Cappello F, 2003, EUR J HISTOCHEM, V47, P105
[3]   Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer [J].
Carpenter, B. ;
Mckay, M. ;
Dundas, S. R. ;
Lawrie, L. C. ;
Telfer, C. ;
Murray, G. I. .
BRITISH JOURNAL OF CANCER, 2006, 95 (07) :921-927
[4]   Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology [J].
Chen, Debo ;
Chen, Fenglin ;
Lu, Xingrong ;
Yang, Xiaosong ;
Xu, Zhongbin ;
Pan, Jie ;
Huang, Ying ;
Lin, Huiming ;
Chi, Pan .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (02) :355-365
[5]   Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer [J].
Coghlin, C. ;
Carpenter, B. ;
Dundas, S. R. ;
Lawrie, L. C. ;
Telfer, C. ;
Murray, G. I. .
JOURNAL OF PATHOLOGY, 2006, 210 (03) :351-357
[6]   Current and emerging concepts in tumour metastasis [J].
Coghlin, Caroline ;
Murray, Graeme I. .
JOURNAL OF PATHOLOGY, 2010, 222 (01) :1-15
[7]   Colorectal cancer [J].
Cunningham, David ;
Atkin, Wendy ;
Lenz, Heinz-Josef ;
Lynch, Henry T. ;
Minsky, Bruce ;
Nordlinger, Bernard ;
Starling, Naureen .
LANCET, 2010, 375 (9719) :1030-1047
[8]   Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers [J].
Curran, S ;
Dundas, SR ;
Buxton, J ;
Leeman, MF ;
Ramsay, R ;
Murray, GI .
CLINICAL CANCER RESEARCH, 2004, 10 (24) :8229-8234
[9]  
Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO
[10]  
2-C